Mohan Singh

Dr. Singh is the Imaging Mass Cytometry (IMC) Program Lead for the Cellular Biomarker Group at GlaxoSmithKline, the global pharmaceutical company. He is a pioneer in the development of high-dimensional spatial discovery assays using IMC. As Scientist-in-Charge of Imaging Mass Cytometry at the USC Michelson Center Convergent Science Institute in Cancer – directed by renowned scientist Dr. Peter Kuhn – he designed and validated novel assays to detect and characterize circulating prostate cancer cells from liquid biopsy samples.